Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01600560 · ClinicalTrials.gov registry record

Facilitating Completion of HPV Vaccination

A clinical trial, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
223
Enrollment target

NCT01600560: Completed study, sponsored by University of North Carolina, Chapel Hill.

NCT01600560 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 223 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01600560 has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
223 participants
Enrollment target

Study Summary

With the surge in use of electronic media among adolescents, a strategy that has been utilized to increase HPV4 uptake in girls has been reminder text messaging to their parents. To date, no published study has looked at the effectiveness of texting adolescents themselves (especially boys) rather than their parents OR compared texting to social network sites to increase HPV knowledge and uptake of HPV vaccination in boys. Interactive technology-based interventions targeted at youth are feasible in North Carolina for the following reasons: (1) through the NC Minors' Consent Law adolescents can consent to the prevention, diagnosis, and treatment of sexually transmitted diseases (N.C. Gen. Stat. § 90-21.5(a); and (2) many school based health centers can provide immunizations. Since HPV infection is a sexually transmitted infection, NC teens do not have to get consent for HPV prevention (i.e., vaccination). To optimize HPV vaccination in young people, especially males, communication strategies are needed to motivate adolescents to get themselves vaccinated. Texting has been demonstrated to be a feasible, popular, and effective method of sexual health promotion to young people with a relatively low withdrawal rate, positive feedback, and an observed improvement in sexual health knowledge and STI testing (12). Social media communication strategies are a new and potentially effective channel for communicating public health messages about HPV vaccine that are also likely to increase HPV initiation and completion among adolescent girls in addition to boys. According to the NC Immunization Registry, as of March 8, 2011, only 2% of boys ages 9-13 had received at least one dose of HPV vaccine. In the investigators continuity clinic less than 50 percent of adolescents are fully immunized. This project will identify social behavioral, emotional, and cognitive correlates and predictors that help explain why teens pursue, complete, and do not complete HPV vaccination, and develop

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2012-05
Est. Completion 2016-07-05

What the finished NCT01600560 record still lists

NCT01600560 is an observational study that tracks outcomes without assigning an intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01600560 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01600560 about?

NCT01600560 is a clinical study titled "Facilitating Completion of HPV Vaccination". With the surge in use of electronic media among adolescents, a strategy that has been utilized to increase HPV4 uptake in girls has been reminder text messaging to their parents. To date, no published study has looked at the effectiveness of texting adolescents themselves (especially boys) rather th...

What is the current status of trial NCT01600560?

This trial is currently completed. The enrollment target is 223 participants. The study started on 2012-05. Estimated completion is 2016-07-05.

Who is sponsoring clinical trial NCT01600560?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06640803 · 223 participants · NA

    Sacramento Clinical High Risk for Psychosis Stepped-Care Program

  • NCT07175285 · 223 participants

    A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  • NCT07205718 · 223 participants · Phase 1

    A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01600560, the US trial registry maintained by the National Library of Medicine. NCT01600560 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.